Characteristics | Non-CVVHDF group (nā=ā12) | CVVHDF group (nā=ā17) | P |
---|---|---|---|
Biochemical data | |||
āPH | 7.21 (6.94, 7.37) | 7.23 (7.07, 7.31) | 0.842 |
āPaO2/FiO2, mmHg | 134 (112.5, 157.8) | 135 (101.5, 160) | 0.757 |
āLac, mmol/L | 4.35 (3.20, 5.80) | 3.5 (2.8, 3.9) | 0.249 |
āCr, Ī¼mol/L | 58.0 (28.5, 79.8) | 48 (28, 77) | 0.757 |
āALT, IU/L | 36.0 (19.8, 63.3) | 35 (13, 70) | 0.894 |
ācTnI, Ī¼g/L | 0.16 (0.06, 0.38) | 0.12 (0.06, 0.39) | 0.877 |
āCK-MB, IU/L | 35 (21, 73) | 37 (26, 112) | 0.308 |
Outcomes | |||
āDuration of mechanical ventilation, day | 14.5 (11.5, 20.3) | 8.0 (5.5, 17.5) | 0.063 |
āDuration of vasoactive agents, day | 7.5 (6.0, 10.0) | 5.0 (4.5, 7.0) | 0.024 |
āStay in PICU, day | 23 (17, 27) | 12 (9, 22) | 0.030 |
ā28-day death, n | 4 | 3 | 0.403 |